Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations

Roflumilast is given as an add-on to inhalation medication in patients with chronic obstructive pulmonary disease (COPD) and chronic bronchitis. Animal experiments have documented deleterious effects of roflumilast in bacterial infections, but trials have not reported the risk of bacterial infection...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Med
Hoofdauteurs: Alispahic, Imane Achir, Sørensen, Rikke, Eklöf, Josefin, Sivapalan, Pradeesh, Løkke, Anders, Seersholm, Niels, Vestergaard, Jakob Hedemark, Jensen, Jens-Ulrik Stæhr
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7291283/
https://ncbi.nlm.nih.gov/pubmed/32408645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9051442
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items